In recent years, targeted therapies have become essential in treating blood cancers such as multiple myeloma. One of these advanced treatments is Darzalex (daratumumab), a monoclonal antibody therapy that works with the immune system.
Read MoreIn recent years, targeted therapies have become essential in treating blood cancers such as multiple myeloma. One of these advanced treatments is Darzalex (daratumumab), a monoclonal antibody therapy that works with the immune system.
Read More
